POAI
Predictive Oncology
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
POAI Profile
Predictive Oncology Inc.
A knowledge-driven company focused on applying artificial intelligence to develop optimal cancer therapies
Healthcare Equipment and Supplies
04/23/2002
08/26/2015
NASDAQ Stock Exchange
23
12-31
Common stock
91 43rd Street, Suite 110 Pittsburgh, Pennsylvania 15201
--
Predictive Oncology Inc., originally established in Minnesota under the name BioDrain Medical, Inc., was established on April 23, 2002. On August 6, 2013, the company changed its name to Skyline Medical Corporation. The company is a knowledge and science driven company that applies artificial intelligence (" AI ") to support the discovery and development of optimal cancer therapies that can ultimately lead to more effective treatments and improve patient outcomes. The company uses AI and a proprietary biobank of 150,000 + tumor samples, classified by tumor type, to provide actionable insights on drug compounds to improve the drug discovery process and increase the probability of success of drug compounds.